HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 4,369-4,380 of 27,277
Drug study icon
Not Yet RecruitingNCT07396870

LY03020 for schizophrenia

What is this study about?

Researchers are comparing LY03020 and placebo to find out how the approaches affect psychotic symptoms in adults with schizophrenia.

This study isn't recruiting yet.

In Beijing
SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
Luye Pharma Group Ltd.
Drug study icon
Not Yet RecruitingACTRN12626001128381

Clinical research study evaluating an investigational study drug (GlyphAgo/SPT-320) in adults with generalized anxiety disorder (GAD) and sleep disturbance.

Official study title

A 6-Week, Multicenter, Monotherapy Trial to Evaluate the Effect of GlyphAgo on Sleep and Anxiety Symptoms in Participants With Generalized Anxiety Disorder and Insomnia Symptoms

This study isn't recruiting yet.

In Australia
AnxietyInterventional studyAges 18–65
Countries
Australia
Sponsor
Seaport Therapeutics
Drug study icon
Not Yet RecruitingNCT07585383

A Phase I study Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult Subjects

Official study title

A Randomized, Double-blind, Placebo-controlled, Dose-escalating Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of Single and Multiple Doses of KR23248 Capsules in Healthy Adult Subjects

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaMedication studyAges 18–45
Countries
Sponsor
Jiangxi Kvvit Pharmaceutical Co., Ltd.
Behavioral study icon
Not Yet RecruitingACTRN12626000475347

A study of Behaviour Activation Therapy combined with ketamine treatment for people with treatment-resistant depression

Official study title

COBAT Pilot: evaluation of the feasibility of implementation, acceptability, and preliminary marginal effectiveness of Co-adapted Behaviour Activation as an adjunct to ketamine for Treatment-resistant depression.

This study isn't recruiting yet.

Multiple locations, including Camperdown
DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
The University of Sydney
Other study type icon
Not Yet RecruitingACTRN12612000801819

A Study of Cardiometabolic Health Nursing in a Community Mental Health Service.

Official study title

Amongst adult community mental health service consumers, is a Cardiometabolic Health Nurse more effective than usual care for improving access to primary care and self-reported health?

This study isn't recruiting yet.

Location not clearly listed
Mental healthInterventional studyAges 18–80
Countries
Sponsor
Brenda Happell

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.